42 related articles for article (PubMed ID: 19794479)
1. Winning WNT: race to Wnt signaling inhibitors.
Watanabe K; Dai X
Proc Natl Acad Sci U S A; 2011 Apr; 108(15):5929-30. PubMed ID: 21451134
[No Abstract] [Full Text] [Related]
2. PARsing the phrase "all in for Axin"- Wnt pathway targets in cancer.
Fearon ER
Cancer Cell; 2009 Nov; 16(5):366-8. PubMed ID: 19878868
[TBL] [Abstract][Full Text] [Related]
3. Wnt/beta-catenin signaling: components, mechanisms, and diseases.
MacDonald BT; Tamai K; He X
Dev Cell; 2009 Jul; 17(1):9-26. PubMed ID: 19619488
[TBL] [Abstract][Full Text] [Related]
4. Drug discovery: Propping up a destructive regime.
Peterson RT
Nature; 2009 Oct; 461(7264):599-600. PubMed ID: 19794479
[No Abstract] [Full Text] [Related]
5. WIKI4, a novel inhibitor of tankyrase and Wnt/ß-catenin signaling.
James RG; Davidson KC; Bosch KA; Biechele TL; Robin NC; Taylor RJ; Major MB; Camp ND; Fowler K; Martins TJ; Moon RT
PLoS One; 2012; 7(12):e50457. PubMed ID: 23227175
[TBL] [Abstract][Full Text] [Related]
6. The ubiquitin-specific protease USP34 regulates axin stability and Wnt/β-catenin signaling.
Lui TT; Lacroix C; Ahmed SM; Goldenberg SJ; Leach CA; Daulat AM; Angers S
Mol Cell Biol; 2011 May; 31(10):2053-65. PubMed ID: 21383061
[TBL] [Abstract][Full Text] [Related]
7. Destruction of a destructor: a new avenue for cancer therapeutics targeting the Wnt pathway.
Liu C; He X
J Mol Cell Biol; 2010 Apr; 2(2):70-3. PubMed ID: 20008332
[TBL] [Abstract][Full Text] [Related]
8. Determinants of Wnt/β-catenin pathway dependency in colorectal cancer.
Scholer-Dahirel A; McLaughlin ME
Cell Cycle; 2012 Jan; 11(1):9-10. PubMed ID: 22157091
[No Abstract] [Full Text] [Related]
9. Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling.
Huang SM; Mishina YM; Liu S; Cheung A; Stegmeier F; Michaud GA; Charlat O; Wiellette E; Zhang Y; Wiessner S; Hild M; Shi X; Wilson CJ; Mickanin C; Myer V; Fazal A; Tomlinson R; Serluca F; Shao W; Cheng H; Shultz M; Rau C; Schirle M; Schlegl J; Ghidelli S; Fawell S; Lu C; Curtis D; Kirschner MW; Lengauer C; Finan PM; Tallarico JA; Bouwmeester T; Porter JA; Bauer A; Cong F
Nature; 2009 Oct; 461(7264):614-20. PubMed ID: 19759537
[TBL] [Abstract][Full Text] [Related]
10. Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer.
Chen B; Dodge ME; Tang W; Lu J; Ma Z; Fan CW; Wei S; Hao W; Kilgore J; Williams NS; Roth MG; Amatruda JF; Chen C; Lum L
Nat Chem Biol; 2009 Feb; 5(2):100-7. PubMed ID: 19125156
[TBL] [Abstract][Full Text] [Related]
11. Tankyrase 1 and tankyrase 2 are essential but redundant for mouse embryonic development.
Chiang YJ; Hsiao SJ; Yver D; Cushman SW; Tessarollo L; Smith S; Hodes RJ
PLoS One; 2008 Jul; 3(7):e2639. PubMed ID: 18612384
[TBL] [Abstract][Full Text] [Related]
12. Tankyrase function at telomeres, spindle poles, and beyond.
Hsiao SJ; Smith S
Biochimie; 2008 Jan; 90(1):83-92. PubMed ID: 17825467
[TBL] [Abstract][Full Text] [Related]
13. Mining the Wnt pathway for cancer therapeutics.
Barker N; Clevers H
Nat Rev Drug Discov; 2006 Dec; 5(12):997-1014. PubMed ID: 17139285
[TBL] [Abstract][Full Text] [Related]
14. The telomeric PARP, tankyrases, as targets for cancer therapy.
Seimiya H
Br J Cancer; 2006 Feb; 94(3):341-5. PubMed ID: 16421589
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
